Wristbands curb nausea brought on by radiation

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 5
Volume 18
Issue 5

Acupressure wristbands help cancer patients who are nauseous from radiation treatment, according to a study in the Journal of Pain and Symptom Management.

Acupressure wristbands help cancer patients who are nauseous from radiation treatment, according to a study in the Journal of Pain and Symptom Management.

In the past, the placebo effect has explained away why the wristbands reduced nausea. In the current study involving 88 people, the researchers set out to see if they could change the patients’ expectations. Lead author Joseph A. Roscoe, PhD, a research associate professor at the University of Rochester Medical Center in New York, found the wristbands still reduced nausea symptoms even with manipulated information.

Dr. Roscoe and colleagues divided the patients into three groups: a wristband group with information about how wristbands aid nausea, a wristband group with more neutral information, and a control group (J Pain Symptom Manage online, 2009 Mar 27).

Nausea fell 23.8% for all the patients who wore wristbands compared with a 4.8% decrease in the control group. No differences were found between the wristband groups.

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content